CVR PARTNERS, LP (UAN): what the price assumes
boothcheck covers CVR PARTNERS, LP (UAN) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/UAN
Headline
| Field | Value |
|---|---|
| Ticker | UAN |
| Company | CVR PARTNERS, LP |
| Current price | $126.71/sh |
| Composition | Ammonia 24% / UAN 62% / Urea products 6% / Other revenue 8% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 6.9% |
| Operating margin today | 28.1% |
| Margin compression (value-band) | -21.2pp |
| Multiple paid | 9x operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 8.8% cost of capital with 4% terminal growth over a 5-year stage.
How unusual the bet is: within-range (limited comparison data)
| Reference | Value |
|---|---|
| vs own history | -0.17σ |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | — | 0 | — |
| Earnings | 0.82x | 5 | justifies |
| Relative | 0.70x | 5 | justifies |
| Growth | 0.53x | 3 | justifies |
Families that justify the price: Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.7%); the inversion above states its own rate.
Per-Model Detail (n=13)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $574.05 | 0.22x | yes | FCF base $0.2B, growth 18% (input: historical growth), terminal g 4.0%, WACC 7.7%, 6yr projection |
| DCF Exit Multiple | Growth | $240.81 | 0.53x | yes | Exit EV/EBITDA: 4.4x / 6.4x / 8.4x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $208.37 | 0.61x | yes | P/E 14x (static sector reference · 2026-04), scenarios: 11.4x / 14.0x / 16.6x (bear / base = reference held flat / bull), EV/EBITDA 8x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | — | — | no | — |
| Two-Stage Excess Return | Asset | — | — | no | — |
| Discounted Future Market Cap | Growth | $133.92 | 0.95x | yes | Rev $0.7B, growth 18% (input: historical growth; tapered), Terminal P/S: 1.6x / 2.0x / 2.3x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $181.80 | 0.70x | yes | EPS $15.15, growth 2% (input: historical EPS growth), PEG=4.18 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $154.04 | 0.82x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.20B × (1−21%) / WACC 7.7% → EPV (no growth) |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | $167.12 | 0.76x | yes | EBITDA $0.28B × sector EV/EBITDA 8.0x |
| FCF Yield | Earnings | $106.60 | 1.19x | yes | FCF $144.6M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $97.54 | 1.30x | yes | SBC-adj FCF $0.14B (FCF $0.14B − SBC $0.01B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $488.84 | 0.26x | yes | EPS $15.15 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $96.05 | 1.32x | yes | Revenue $0.68B × sector P/S 1.5x |
| PEG Fair Value | Relative | $568.13 | 0.22x | yes | EPS $15.15 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $163.78 | 0.77x | yes | EPS $15.15 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $432.3m |
| Net debt / NOPAT (after-tax) | 2.88x |
| Net debt / operating income (pre-tax) | 2.27x |
| Share count CAGR (dilution) | 0.0% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- CVR Partners is a nitrogen fertilizer producer structured as a variable-distribution partnership, where the Coffeyville plant's use of petroleum coke rather than natural gas as its main feedstock gives it a cost position most rivals do not share.
- The number that defines the unit is the distribution swinging with the cycle: the board declared $4.00 per common unit for Q1 2026, a payout that rises and falls with nitrogen prices rather than a fixed dividend.
- The risk is that today's 23.6% operating margin reflects an unusually tight nitrogen market, one the company says was amplified by Middle East conflicts, so the question is how much of current earnings is cyclical peak versus sustainable.
Bull Case
The fear with any commodity producer is that it has no cost advantage and simply rides the market down with everyone else. CVR Partners is the counterexample, and the data supports it. The Coffeyville facility runs on petroleum coke rather than natural gas, the feedstock most nitrogen producers depend on, and that single difference decouples a large part of its cost base from the gas market that drives competitors' economics. The 10-K describes the pet coke it buys from CVR Energy's adjacent refinery and third parties as central to production, and notes that the facility "could utilize natural gas as an optional feedstock to pet coke" if it ever chose to, optionality that cuts the other way: the plant can lean on whichever input is cheaper. In a year of elevated gas prices, the pet-coke producer keeps making money while gas-based rivals get squeezed.
The operational performance shows the asset running hot and well. CVR Partners posted a combined ammonia utilization rate of 103% in Q1 2026, produced 220,000 tons of ammonia and 335,000 tons of UAN, and translated that into net income of $50 million, or $4.72 per common unit, against $27 million a year earlier. UAN, the upgraded product, commands a premium to urea and ammonia on a nitrogen-equivalent basis per the filing, and it made up roughly 67% of net sales for the year. This is a plant operating above nameplate and selling its highest-value product into a strong market.
The partnership structure turns that into direct cash for holders. CVR Partners declared a $4.00 per common unit distribution for the quarter, passing the cash through rather than retaining it. And there is a growth lever: the Board has approved initial stages of a project that could let Coffeyville import larger quantities of hydrogen from the adjacent refinery and "increase the nameplate ammonia production", a low-cost capacity addition that leverages existing infrastructure. For an investor who wants commodity exposure with a structural cost edge and a payout that participates fully in the upside, the unusual feedstock position is the reason to own it rather than a generic peer.
Bear Case
Begin with what the balance sheet does under stress, because for a commodity partnership that is where the risk concentrates. CVR Partners carries net debt of about $442 million against trailing operating income of roughly $152 million, near three times, and the business it supports is one of the most volatile in the materials complex. The 10-K is blunt about the working-capital whipsaw: "nitrogen fertilizer demand volatility can significantly impact working capital on a week-to-week and month-to-month basis", and if the partnership cannot "secure sufficient liquidity to meet our working capital needs" it may be unable to meet debt obligations or pursue its strategy. Liquid assets of about $128 million are a cushion, but a downcycle in nitrogen prices compresses cash flow and the distribution at the same time the debt stays fixed. The distribution is the shock absorber, and unitholders bear the swing.
The earnings are commodity earnings, and the filing leaves no room to pretend otherwise. Demand for the products is "dependent on fluctuating demand for crop nutrients by the global agricultural industry" with fluctuations that "historically have had and could in the future have" a material adverse effect, and the products themselves are "globally traded commodities and are subject to price competition" where customers buy principally on delivered price. There is no brand, no switching cost, no recurring revenue. There is a cost position and a price the world sets. When the price falls, the margin falls with it, and the current 23.6% operating margin is a function of a tight market rather than anything durable about the business.
That tight market is the most fragile assumption in the price. The company itself attributes the strength to nitrogen-market tightness that began in 2025 and was amplified by Middle East conflicts pushing spring prices higher. Average realized gate prices reached $687 per ton for ammonia and $343 per ton for UAN in Q1 2026. Those are good prices, and good prices in a commodity are mean-reverting by nature. The bear case is not that CVR Partners is mismanaged; it is that the current earnings and the current distribution both sit near a cyclical high, and the price assumes a normalization that may run deeper than the methods built on trailing peak margins suggest.
Valuation
The methods we use to triangulate cluster below the price, which is the normal pattern for a commodity name at a strong point in its cycle, and reading it correctly matters. The growth-cash-flow and earnings-power approaches land beneath the current unit price, and the peer-multiple lens sits modestly below it as well. Inverted, the price embeds a forward operating margin of under 7%, well below the 23.6% the partnership earns today. That is not the market saying the units are cheap; it is the market already discounting the current margin as a peak that does not persist, exactly the discipline a cyclical demands.
The concrete bet is about the gap between peak and mid-cycle. Today's margin reflects nitrogen-market tightness the company attributes to conditions that began in 2025 and were amplified by geopolitical conflict. The price requires only a fraction of that margin to hold, which is a sensible bet for an asset with a structural feedstock advantage, but it is still a bet that mid-cycle economics support the current unit price plus its distribution stream. The methods built on trailing peak earnings will always look generous near a cyclical top; the honest read is that the price is paying for a normalization that lands somewhere between today's tightness and the troughs the filing warns can recur.
Solvency frames how much cushion there is for that normalization, and it closes the question. Net debt near three times trailing operating income is moderate at peak margins but tightens quickly if nitrogen prices fall, and the partnership's own language flags the working-capital volatility that comes with the territory. The distribution absorbs the cyclical swing, which protects the balance sheet but transfers the variability straight to the unitholder. The asset is real and advantaged; the price is a wager on where nitrogen settles, not on whether the plant runs.
Catalysts
Q1 2026 was a strong print driven by a tight market. CVR Partners reported net income of $50 million, or $4.72 per common unit, and EBITDA of $78 million on net sales of $180 million, against $27 million of net income and $53 million of EBITDA a year earlier. Combined ammonia utilization ran at 103%, with 220,000 tons of ammonia and 335,000 tons of UAN produced, and average realized gate prices of $687 per ton for ammonia and $343 per ton for UAN.
The cash followed the earnings. The Board declared a $4.00 per common unit distribution, payable May 18, 2026 to holders of record May 11. Because the distribution is variable, it is itself the clearest forward signal: it tracks realized prices and utilization quarter by quarter rather than committing to a fixed payout.
The catalyst that governs everything is the nitrogen price itself. The company tied the spring strength to market tightness amplified by Middle East conflicts, which means the next several quarters hinge on whether that geopolitical premium holds or fades and on planting-season demand. For the longer term, the approved early stages of the Coffeyville capacity project are the structural item to track, a potential low-cost increase in ammonia output that would lift volumes independent of price.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- SMG (Scotts Miracle-Gro Co)
- FY2025 10-K: …The Home Depot and Lowe's are our two largest customers and are the only customers that individually represent more than 10% of reported consolidated net sales during any of the three most recent fiscal years. For additional details regarding significant customers, see "ITEM 1A. RISK FACTORS - Risks Related to Our…
- FY2025 10-K: …• lower material costs in our U.S. Consumer segment; • lower sales volume in our Hawthorne segment; and • a decrease in impairment, restructuring and other charges; • partially offset by higher sales volume in our U.S. Consumer segment; • inventory write-down charges included within "volume, mix and other" associated…
- CF (CF INDUSTRIES HOLDINGS, INC.)
- FY2025 10-K: …to the cost of natural gas used to produce ammonia, and (iii) higher realized natural gas costs, including the impact of realized derivatives, for our North American operations. Gross Margin . Gross margin in our AN segment was $79 million in both 2025 and 2024, and our gross margin percentage was 18.8% in 2025…
- FY2025 10-K: These segments are differentiated by products. We use gross margin to evaluate segment performance and allocate resources. Total other operating costs and expenses (consisting primarily of selling, general and administrative expenses and other operating-net) and non-operating expenses (consisting primarily of interest…
- MOS (MOSAIC CO)
- FY2025 10-K: …and administrative expenses. The segment results may not represent the actual results that would be expected if they were independent, stand-alone businesses. Intersegment eliminations, including profit on intersegment sales, mark-to-market gains/losses on derivatives, debt expenses and the results of the China and…
- FY2025 10-K: …Fertilizantes segment's production of crop nutrient dry concentrates and animal feed ingredients remained materially unchanged from the prior year period at 3.5 million tonnes. For the years ended December 31, 2025 and 2024 our phosphate operating rate was 78%. Our Brazilian phosphate rock production increased to 4.2…
- NEU (NEWMARKET CORPORATION)
- FY2025 10-K: …have need for the quantities required to be purchased under commitment agreements, we could incur additional charges that would affect our profitability. • Lack of availability of raw materials, including sourcing from some single suppliers, could negatively impact our ability to meet customer demand. The chemical…
- FY2025 10-K: …to our operations. These impacts could include supply chain disruptions, lower customer demand, and higher costs. Investing in technology to meet customer needs, enhancing our operational efficiency, and improving our portfolio profitability will remain priorities. Despite the challenging economic environment, our…
- PRM (PERIMETER SOLUTIONS, INC.)
- FY2025 10-K: …better than any alternative in every market we serve. We aim to maximize our organic reinvestment into our business to best serve our customers and to support the rigorous application of our Operational Value Drivers: seeking out profitable new business, structurally improving operational productivity, and sharing in…
- FY2025 10-K: …span firefighting products, lubricant additives, electronic components and, following the acquisition of Medical Manufacturing Technologies, LLC ("MMT") in January 2026, highly engineered machinery for the medical device industry. We develop products that address complex customer challenges where there is little…
- IOSP (INNOSPEC INC.)
- FY2025 10-K: …and Chief Executive Officer (the Principal Executive Officer). The CODM evaluates the performance of the Company's segments and makes strategic decisions relating to the Company's allocation of resources, based on the segments' monthly gross profit and operating income. The following table analyzes financial…
- FY2025 10-K: …Registration of Marks" are registered in all jurisdictions in which the Company has a significant market presence. The Company also has trademark registrations for certain product names in all jurisdictions in which it has a significant market presence. We actively protect our inventions, new technologies, and…
- NGVT (INGEVITY CORPORATION)
- FY2025 10-K: …production for ICE powertrains compared to the prior year. We expect Net sales in our Performance Chemicals reportable segment, inclusive of the road markings product line, to grow mid-single digits through continued adoption of our warm mix asphalt products in our pavement technologies product line. For our Advanced…
- FY2025 10-K: …recurring expenses necessary to operate our business, we have excluded the CTO resale (income) charges for the purposes of calculating our non-GAAP financial performance measures. For the years ended December 31, 2024 and 2023, the loss on CTO resales relates to the Performance Chemicals segment. Refer to Note 20 for…
- ESI (Element Solutions Inc)
- FY2025 10-K: …We also face competition from many smaller companies that specialize in particular segments of the markets in which we compete. 7 The specific competitive environment of each of our segments is described below: Electronics Our Electronics segment provides a broad line of proprietary chemical technologies, materials…
- FY2025 10-K: …for the deep-water oil extraction and transportation process, and drilling fluids are used to operate valves for drilling rigs on the ocean floor. Production and drilling fluids are water-based hydraulic fluids used in subsea control systems. Competitive Strengths We believe the following competitive strengths…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
CVR Partners Q1 2026 results, April 29 2026